To validate our WNT5A and LGR5 survival results (Figure 1), we assessed data for 274 patients from the colon cancer cohort TCGA-COAD who provided colon cancer tissue mRNA samples. This evidence concerns the gene WNT5A and malignant colon neoplasm.